JavaScript is disabled for your browser. Some features of this site may not work without it.
Statistics
Total Visits
| Views | |
|---|---|
| High p16 expression and heterozygous RB1 loss are biomarkers for CDK4/6 inhibitor resistance in ER+ breast cancer | 11 |
Total Visits Per Month
| November 2022 | December 2022 | January 2023 | February 2023 | March 2023 | April 2023 | May 2023 | |
|---|---|---|---|---|---|---|---|
| High p16 expression and heterozygous RB1 loss are biomarkers for CDK4/6 inhibitor resistance in ER+ breast cancer | 0 | 0 | 0 | 11 | 0 | 0 | 0 |
File Visits
| Views | |
|---|---|
| Palafox_nc_high.pdf | 5 |
Top country views
| Views | |
|---|---|
| United States | 9 |
| Spain | 2 |
Top cities views
| Views | |
|---|---|
| San Ramon | 5 |
| Barcelona | 2 |
| Redmond | 2 |
| Ann Arbor | 1 |
| San Diego | 1 |
